Abstract Library

#3532 Bone loss and whole-body composition in patients with gastroenteropancreatic neuroendocrine neoplasms

Introduction: Patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are at increased risk for osteoporosis, but data on muscle and fat mass are scarce.

Conference:

Presenting Author: Tsoli M

Authors: Aktypis C, Tsoli M, Yavropoulou M, Efstathopoulos E, Kassi E,

Keywords: bone mineral density, osteoporosis, fat mass, sarcopenia, gastroenteropancreatic neoplasm,

#3448 Differential diagnosis of diarrhoea in patients with neuroendocrine tumors

Introduction: Patients with neuroendocrine tumors (NETs) frequently experience diarrhoea that can impact their quality of life. Pancreatic enzyme insufficiency (PEI), bile acid diarrhoea (BAD) and small intestinal bacterial overgrowth (SIBO) are potential causes. There is a limited data on prevalence of these conditions in NETs.

Conference:

Presenting Author: Navaratnam J

Authors: Navaratnam J, Reed H, Sivananthan M, Rela A, Khan M,

Keywords: Neuroendocrine, Research, Diarrhoea, Quality of LIfe,

#1698 Assessment of Small Intestinal Bacterial Overgrowth (SIBO) in NET Patients

Introduction: SIBO is not uncommon in NETs. Hydrogen Breath testing (HBT) using glucose may be more sensitive to proximal SIBO as glucose rarely reaches the colon. Many NET patients are likely to have distal SIBO however, as factors such as ileocecal valve removal apparently increase distal SIBO risk. Thus glucose BT alone may limit sensitivity for detecting SIBO in some NET diagnoses.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Whyand T, Koffas A, Toumpanakis C, Mandair D, Caplin M,

Keywords: nets, sibo, dysbiosis, ,